[article]
| Titre : |
Psychiatric Comorbidity and Medication Use in Adults with Autism Spectrum Disorder |
| Type de document : |
texte imprimé |
| Auteurs : |
Tara R. BUCK, Auteur ; Joseph VISKOCHIL, Auteur ; Megan FARLEY, Auteur ; Hilary H. COON, Auteur ; William M. MCMAHON, Auteur ; Jubel MORGAN, Auteur ; Deborah A. BILDER, Auteur |
| Article en page(s) : |
p.3063-3071 |
| Langues : |
Anglais (eng) |
| Mots-clés : |
Autism spectrum disorder Psychiatric comorbidity Psychotropic medication Intellectual disability |
| Index. décimale : |
PER Périodiques |
| Résumé : |
The purpose of this study was to investigate comorbid psychiatric disorders and psychotropic medication use among adults with autism spectrum disorder (ASD) ascertained as children during a 1980’s statewide Utah autism prevalence study (n = 129). Seventy-three individuals (56.6 %) met criteria for a current psychiatric disorder; 89 participants (69.0 %) met lifetime criteria for a psychiatric disorder. Caregivers reported a psychiatric diagnosis in 44 participants (34.1 %). Anxiety disorder had the highest current and lifetime prevalence (39.5 and 52.7 %, respectively). Participants with intellectual disability (n = 94, 72.8 %) were significantly less likely to have community-based diagnoses of anxiety (χ2 = 5.37, p = 0.02) or depression (χ2 = 13.18, p 0.001) reported by caregivers. Seventy-six participants (58.9 %) were taking ≥1 psychotropic medication. Comorbid psychiatric disorders occur frequently in adults with ASD, though identifying these disorders poses a challenge in community settings. A greater understanding of the presentation of these conditions within this population will increase assessment validity and the potential for efficacious intervention. |
| En ligne : |
http://dx.doi.org/10.1007/s10803-014-2170-2 |
| Permalink : |
https://www.cra-rhone-alpes.org/cid/opac_css/index.php?lvl=notice_display&id=243 |
in Journal of Autism and Developmental Disorders > 44-12 (December 2014) . - p.3063-3071
[article] Psychiatric Comorbidity and Medication Use in Adults with Autism Spectrum Disorder [texte imprimé] / Tara R. BUCK, Auteur ; Joseph VISKOCHIL, Auteur ; Megan FARLEY, Auteur ; Hilary H. COON, Auteur ; William M. MCMAHON, Auteur ; Jubel MORGAN, Auteur ; Deborah A. BILDER, Auteur . - p.3063-3071. Langues : Anglais ( eng) in Journal of Autism and Developmental Disorders > 44-12 (December 2014) . - p.3063-3071
| Mots-clés : |
Autism spectrum disorder Psychiatric comorbidity Psychotropic medication Intellectual disability |
| Index. décimale : |
PER Périodiques |
| Résumé : |
The purpose of this study was to investigate comorbid psychiatric disorders and psychotropic medication use among adults with autism spectrum disorder (ASD) ascertained as children during a 1980’s statewide Utah autism prevalence study (n = 129). Seventy-three individuals (56.6 %) met criteria for a current psychiatric disorder; 89 participants (69.0 %) met lifetime criteria for a psychiatric disorder. Caregivers reported a psychiatric diagnosis in 44 participants (34.1 %). Anxiety disorder had the highest current and lifetime prevalence (39.5 and 52.7 %, respectively). Participants with intellectual disability (n = 94, 72.8 %) were significantly less likely to have community-based diagnoses of anxiety (χ2 = 5.37, p = 0.02) or depression (χ2 = 13.18, p 0.001) reported by caregivers. Seventy-six participants (58.9 %) were taking ≥1 psychotropic medication. Comorbid psychiatric disorders occur frequently in adults with ASD, though identifying these disorders poses a challenge in community settings. A greater understanding of the presentation of these conditions within this population will increase assessment validity and the potential for efficacious intervention. |
| En ligne : |
http://dx.doi.org/10.1007/s10803-014-2170-2 |
| Permalink : |
https://www.cra-rhone-alpes.org/cid/opac_css/index.php?lvl=notice_display&id=243 |
|  |
Psychiatric Comorbidity and Medication Use in Adults with Autism Spectrum Disorder in Journal of Autism and Developmental Disorders, 44-12 (December 2014)
